Bonti, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bonti, Inc. - overview
Established
2015
Location
Newport Beach, CA, US
Primary Industry
Biotechnology
About
Founded in 2015 and based in California, US, Bonti, Inc. is a biotechnology company that develops neurotoxins for therapeutic and aesthetic use. The company's CEO is Fauad Hasan, and CFO is David Ramsay, who served as CFO of Halozyme Therapeutics, Inc which is a public company. As of January 2018, the company has raised USD 36 million.
The company's product candidate, EB-001, is an investigational botulinum neurotoxin serotype E (BoNT/E) that is used for post-surgical pain. Though BoNT/E has a similar action mechanism to the marketed BoNT/A products, it has a differentiated clinical profile. The BoNT/E has a fast onset of action (within 24 hours) and a short duration of effect (about 3 to 4 weeks), while the BoNT/A has an onset of action around 3 to 7 days, and duration of effect around 3 to 4 months. BoNT/E can be used in aesthetic and therapeutic uses, including for the treatment of post-surgical and non-surgical musculoskeletal pain.
The company will use the Series C funding to continue developing EB-001, including a first Phase 2 pain study, LANTERN-1 (Long-Acting NeuroToxin-E Relief, Non-opioid), a second Phase 2 pain study (LANTERN-2), and preparing for an End of Phase 2 FDA meeting.
Current Investors
Colt Ventures, City Hill Ventures, HighLight Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Aesthetic Medicine, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Website
www.bonti.com
Verticals
HealthTech, Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Bonti, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.